You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
2005, Volume 12, Issue 03, pages 161-244
CLINICAL ARTICLE
Br J Cardiol 2005;12:243-4
Heart failure management – a secondary care perspective
In the previous article, Dr Sarah Jarvis provides a useful perspective
on the management of heart failure in primary care. Recent reports
from the Department...
CLINICAL ARTICLE
Br J Cardiol 2005;12:240-3
Heart failure management in primary care – the story so far
Increasing rates of coronary heart disease and the increasing longevity of the UK population mean that the number of cases of heart failure seen in...
CLINICAL ARTICLE
Br J Cardiol 2005;12:233-8
The diagnosis and management of heart failure across primary-secondary care: a qualitative study
The management of heart failure has altered greatly and good outcomes are dependent on an accurate, specific diagnosis and modern therapy. In 50% of cases,...
CLINICAL ARTICLE
Br J Cardiol 2005;12:230-31
Coronary spasm as a cause of sudden death induced by malignant ventricular arrhythmia
Coronary artery spasm is an uncommon presentation of angina and may be associated with other vasospastic diseases such as Raynaud’s disease. It is widely accepted...
CLINICAL ARTICLE
Br J Cardiol 2005;12:224-9
Can we treat heart failure effectively and maintain potassium homeostasis? A clinician’s perspective
Hypokalaemia and hyperkalaemia are common complications of heart failure and its treatment: either may increase markedly the risk of arrhythmias and sudden cardiac death. Hypokalaemia...
CLINICAL ARTICLE
Br J Cardiol 2005;12:219-23
Sleep-disordered breathing and heart failure: an opportunity missed?
Sleep-disordered breathing (SDB) is common in patients with congestive heart failure (CHF). SDB appears to be associated with accelerated progression of heart failure. However, it...
CLINICAL ARTICLE
Br J Cardiol 2005;12:211-8
Aldosterone: an important mediator of cardiac remodelling in heart failure
Aldosterone is intimately linked to the pathophysiology of heart failure, and high levels of aldosterone are associated with worse prognosis. Many non-renal effects of aldosterone...
CLINICAL ARTICLE
Br J Cardiol 2005;12:205-8
Heart failure after myocardial infarction: a neglected problem?
Improvements in the management of acute myocardial infarction together with population ageing have contributed to a growing burden of heart failure. Around half of new...
NEWS
Br J Cardiol 2005;12:192-8
National variations in the provision of cardiac services in the United Kingdom
We publish in full this report by a working group of the British Cardiac Society which shows large disparities in cardiac services between England, Scotland,...
EDITORIAL
Br J Cardiol 2005;12:175-8
Prevention of heart failure: further insight from B-type natriuretic peptide
Major advances have been made in the management
of heart failure (HF) over recent years. Modern day
pharmacotherapy and device-based therapy have
brought about significant...
EDITORIAL
Br J Cardiol 2005;12:171-2
Sleep-disordered breathing in congestive heart failure: an opportunity missed?
The review by Vazir and colleagues in this issue of the journal
(see pages 219–23) comes as a timely and practical
update on the implications, diagnosis...
EDITORIAL
Br J Cardiol 2005;12:167-8
Cardiac services in the UK: are some areas more equal than others?
The Department of Health has supported the standards
and targets set in the National Service Framework (NSF)
for coronary heart disease (CHD) with a programme...